Compound 1221
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nc(nc2CN(CCc12)[C@H]1CCN(Cc2ccccc2-c2ccc(Cl)cc2)C[C@@H]1F)C(F)(F)F
- InChi:
InChI=1S/C45H47ClF7N7O4S3/c1-58(2)21-18-32(28-65-33-9-4-3-5-10-33)54-38-17-16-34(24-41(38)66(61,62)45(51,52)53)67(63,64)57-42-36-19-23-60(27-39(36)55-43(56-42)44(48,49)50)40-20-22-59(26-37(40)47)25-30-8-6-7-11-35(30)29-12-14-31(46)15-13-29/h3-17,24,32,37,40,54H,18-23,25-28H2,1-2H3,(H,55,56,57)/t32-,37+,40+/m1/s1
- InChiKey:
XYITYONGQARSQX-JOJMXTOGSA-N
External links
![]() 168317822 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 69 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.33 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 1013.24 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 8.67 | |||
TPSA | 127.84 | |||
RB | 17 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 69 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.33 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4657 | Navitoclax | DB12340 | |
0.4064 | GDC-0349 | DB13072 | |
0.3885 | Sulfaisodimidine | DB13283 | |
0.3859 | Gemigliptin | DB12412 | |
0.3710 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3654 | Presatovir | DB12165 | |
0.3651 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3531 | Bleomycin | DB00290 | |
0.3525 | Sparsentan | DB12548 | |
0.3498 | Lenacapavir | DB15673 | |
0.3489 | Sulfametomidine | DB13485 | |
0.3480 | Vintafolide | DB05168 | |
0.3463 | Quinupristin | DB01369 | |
0.3460 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3446 | Sufugolix | DB06494 |